
The NeuroLife® platform is a non-invasive technology designed to sense, decode, and stimulate neuromuscular activity with high resolution.
By combining wearable hardware with intelligent algorithms, we provide a data-driven path to functional recovery.

The process begins with our wearable, non-invasive sleeve.
High-density EMG arrays capture detailed neuromuscular signals directly from the skin.
These arrays are designed to pick up subtle electrical patterns that reflect a patient’s movement intent.
The wearable form factor eliminates the need for invasive procedures or restrictive lab settings.
Once signals are captured, our proprietary software takes over to interpret the data.

Normalized RMS activity mapped to the sleeve orientation, with a legend showing the orientation of the sleeve mapping (flex.=flexors, ext.=extensors). Note the location of EMG activity is spatially located near the related musculature for each of the 3 movements.
The system uses specialized calibration methods to ensure ease of setup and consistent performance across different therapy sessions.
Intelligent decoding algorithms translate complex muscle activation patterns into actionable information.
This provides clinicians with immediate, signal-driven data regarding the patient's neuromuscular state.

The platform completes the loop by helping the patient achieve functional movement.
Adaptive stimulation is designed to support the functional use of the upper limb during guided rehabilitation.
The stimulation is not generalized; it is tailored to the individual’s signals to support more personalized recovery goals.
Early human studies suggest the platform helps patients engage in meaningful hand and arm movements during therapy.
We designed NeuroLife to fit into the way clinicians already work.
Built with direct input from PTs, OTs, and physiatrists to align with real-world workflows.
A flexible design that allows for repeated use and potential future integration with digital health tools.
By focusing on a wearable format, we improve patient comfort and adoption compared to implant-based technologies.

